載入...
Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a risk factor for colorectal cancer (CRC). We evaluated chemotherapy tolerance and oncologic outcomes from the medical records of patients with CRC with and without IBD. In this series, patients with CRC with IBD experienced more treatment alterations than those w...
Na minha lista:
| 發表在: | Clin Colorectal Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6009836/ https://ncbi.nlm.nih.gov/pubmed/27742264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2016.09.005 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|